BackMolecular Data Overview

Molecular Data Total Revenue

Latest total revenue for MKD: $13B, below the Industrials sector average of $380B.

Get informed when a big investor buys or sells

+ Follow

Quarterly Revenue

$2.90B
28.58% YoY

As of Dec 2020

Annual Revenue (TTM)

$13.21B

Trailing 12 months ending Dec 2020

Average Revenue (Comparison Companies)

Loading

Total Revenue History

Loading

Total Revenue Comparison

Loading

Annual Revenue Growth Rate (%)

Loading

Annual Revenue Growth (Absolute)

Loading

Molecular Data (MKD) FAQ

Molecular Data's total revenue stands at $13B as of December 2020. That is below the Industrials sector average of $380B. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Molecular Data sits lower the Industrials benchmark ($380B) with a total revenue of $13B. That is roughly 96.5% below the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.

Open the history chart to see whether Molecular Data's total revenue is expanding or contracting. Sustained growth in total revenue can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how Molecular Data's total revenue evolved across reporting periods, while the comparison chart places MKD next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Industrials, total revenue is commonly used to spot outliers. Molecular Data's reading of $13B (sector avg $380B) is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.